IV Bag Infections at Alabama Hospitals Linked to Filtering Problems

|

An outbreak of deadly infections at six Alabama hospitals, which resulted in the death of at least 9 people and serious infections for at least 10 others, has been linked to problems with a filtering system that did not remove certain bacteria at a medical laboratory that made IV bags used at the hospitals.

According to the latest findings of the Alabama Department of Public Health, Serratia marcescens bacteria was found at the facility where intravenous feeding liquids were made. Officials are continuing to investigate why the filtering system used at the medical laboratory did not remove the bacteria.

Last month, Meds IV, an Alabama compounding pharmacy shut their doors and issued a recall for IV bags that contained a liquid nutrient known as Total Parenteral Nutrition (TPN). The recall was issued after an outbreak of infections involving Serratia marcescens bacteria was identified at six different Alabama hospitals where the IV bags were used.

Sports-Betting-Addiction-Lawsuits
Sports-Betting-Addiction-Lawsuits

At least three lawsuits over the Alabama hospital infections have been filed, including two wrongful death suits. Additional claims are expected from patients who suffered infections due to Serratia marcescens bacteria.

The Alabama hospitals known to have received the tainted IV bags include Baptist Princeton, Baptist Shelby, Baptist Prattville, Medical West, Cooper Green Mercy and Select Specialty Hospital in Birmingham.

Serratia marcescens is a waterborne bacteria that can cause fever, respiratory problems and shock. The Alabama Department of Public Health investigators found bacteria on a faucet and medical equipment at the Meds IV lab. The company has since decided to cease operations and officials with the Centers for Disease Control and Prevention (CDC) have indicated that it is unlikely the business will reopen.


0 Comments


Share Your Comments

This field is hidden when viewing the form
I authorize the above comments be posted on this page
Post Comment
Weekly Digest Opt-In

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

This field is for validation purposes and should be left unchanged.

MORE TOP STORIES

A mediator has been appointed to oversee settlement discussions between parties involved in an Oxbryta class action lawsuit, which claims the recalled drug endangered sickle cell disease patients.
A BioZorb side effects lawsuit indicates that a woman is suffering chronic pain and soreness after the tissue marker implant failed to absorb into her body as advertised.